Molecular and Clinical Advances in Anticancer Drug Resistance: 57 (Cancer Treatment and Research, 57) - Image 1

£165.95

Springer Molecular and Clinical Advances in Anticancer Drug Resistance: 57 (Cancer Treatment and Research, 57)

Name: Molecular and Clinical Advances in Anticancer Drug Resistance: 57 (Cancer Treatment and Research, 57)
Brand: Springer
Price: 168.56 GBP
Availability: InStock

Oncology

Price History & Forecast

Last 75 days • 75 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 75 days • 2 price levels

Days at Price

Current Price

Price Analysis

Most common price: £166 (70 days, 93.3%)

Price range: £166 - £169

Price levels: 2 different prices over 75 days

Description

Product Description The importance of drug resistance in cancer chemotherapy cannot be over stated. The 500,000 patients who die every year from cancer in the United States have, in most cases, been treated with chemotherapy. Many of these patients responded initially to chemotherapy, but death resulted from the development of drug-resistant tumors. In the first volume in the series. Drug Resistance in Chemotherapy the results of comprehensive laboratory studies aimed at understanding the mechanisms for resistance to individual agents and to the development of broad cross-resistance were described. In the past 2 years there has been substantial progress in understanding the molecular biology associated with these mechanisms of drug resistance. For the first time we are starting to understand which mechanisms are playing an im portant role in human tumors, and even more importantly, clinical trials have recently been initiated in an effort to reverse specific forms of drug resistance. The purpose of this volume is to describe the new advances, both at the molecular level and in the clinic regarding mechanisms of drug resistance and potential ways this resistance can be circumvented. This volume is focused upon mechanisms of resistance associated with two major classes of anticancer drugs: alkylating agents (including cisplatin) and the natural products (e. g. , adriamycin and vinblastine). The first section of the book describes new insights into the genetic mechanisms associated with drug resistance. Review ' This book contains much valuable information, including an extensive bibliography. As such, it is primarily of value as a reference text both for clinical and basic scientific research staff. ' Journal of the National Cancer Institute 84:22 1992 'This book would be a helpful text for basic researchers, clinical investigators, and medical housestaff. It is well written and can be read in a relatively short period of time. ' Breast Cancer Research and Treatment 19 1991

Product Specifications

Brand: Springer
Format: hardcover
ASIN: 0792312120
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders > Oncology
Domain: Amazon UK
Release Date: 30 September 1991
Listed Since: 09 December 2006

Barcode

No barcode data available

Springer Molecular and Clinical Advances in Anticancer Drug Resistance: 57 (Cancer Treatment and Research, 57)

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Molecular and Clinical Advances in Anticancer Drug Resistance: 57 (Cancer Treatment and Research, 57)

Anticancer Drug Resistance: Advances in Molecular and Clinical Research: 73 (Cancer Treatment and Research, 73)

Multi-Drug Resistance in Cancer: 596 (Methods in Molecular Biology, 596)

Multi-Drug Resistance in Cancer: 596 (Methods in Molecular Biology, 596)

Cancer Drug Resistance (Cancer Drug Discovery and Development)

Cytotoxic Drug Resistance Mechanisms: 28 (Methods in Molecular Medicine, 28)

Drug Resistance in Cancer Cells

Multiple Drug Resistance in Cancer: Cellular, Molecular and Clinical Approaches: v. 1

Springer - Molecular Mechanisms of Tumor Cell Resistance

Progress in Cancer Drug Resistance Research

Cancer Drug Resistance: Overviews and Methods: 1395 (Methods in Molecular Biology, 1395)

Biological Mechanisms and the Advancing Approaches to Overcoming Cancer Drug Resistance (Volume 12) (Cancer Sensitizing Agents for Chemotherapy, Volume 12)

Drug Resistant Neoplasms (Cancer Etiology Diagnosis and Treatment Series)

Targeted Therapies: Mechanisms of Resistance (Molecular and Translational Medicine)

Springer - Therapeutic Resistance to Anti-hormonal Drugs Book

Cancer Therapeutics: Experimental and Clinical Agents (Cancer Drug Discovery and Development)

Molecular Oncology: Underlying Mechanisms and Translational Advancements

Targeted Therapies: Mechanisms of Resistance (Molecular and Translational Medicine)

Resistance to Targeted ABC Transporters in Cancer: 4 (Resistance to Targeted Anti-Cancer Therapeutics)

Macromolecular Anticancer Therapeutics (Cancer Drug Discovery and Development)

Macromolecular Anticancer Therapeutics (Cancer Drug Discovery and Development)

Drug Resistance in Leukemia and Lymphoma III: 457 (Advances in Experimental Medicine and Biology, 457)

Drug Resistance in Leukemia and Lymphoma III: 457 (Advances in Experimental Medicine and Biology, 457)

Cancer Drug Resistance (Cancer Drug Discovery and Development)